Abstract
Introduction

1
Of all gastrointestinal malignancies, pancreatobiliary carcinomas continue to have poor 2 survival rates. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Multiple studies have examined potential prognostic factors in patients 3 undergoing resection for extrahepatic cholangiocarcinoma, including the presence of lymph 4 node metastases, 2, 3, 5, 6, [8] [9] [10] [11] [12] the number of lymph node metastases, 11,12 resection margin, 1, 3, [5] [6] [7] [8] [9] 5 tumor differentiation, 1,9 and depth of invasion. 7, 12 There is increasing evidence that the GPS, 6 a score based on the systemic inflammatory response (SIR) that evaluates CRP and albumin 7 serum levels, is a useful scoring system to determine the prognosis of patients with 8 advanced cancers. [13] [14] [15] The SIR encompasses the infiltration of proinflammatory 9 lymphocytes, which produce cytokines and chemokines within the tumor 10 microenvironment, predisposing the tumor to further progression, invasion, and 11 metastases. 16 A state of chronic inflammation is thought to play a key role in the initiation,
Patients and Methods
1
This study retrospectively analyzed 62 consecutive patients (41 men and 21 women)
were fixed in 10% formalin for several days, and then serially sectioned at 5-mm intervals.
23
Specimens were prepared in the standard manner for microscopic examination by hematoxylin and eosin staining. Histopathological findings were described in accordance In the patients who underwent the biliary drainage procedures, we diagnosed whether 9 they had cholangitis or not according to systemic inflammatory response syndrome (SIRS) 10 criteria; including fever, abnormal white blood cell count, tachypnea, and tachycardia, as 11 well as filthy colored bile juice which is suspect of bile contamination. Blood samples were 12 always taken from the patients within one week before surgery in order to confirm there
13
were no other problems or abnormality in the patients prior to receiving anesthesia and 14 surgery. We used the blood sample data at that time; i.e., serum CRP and albumin for the 15 GPS system. In the present study, we used the blood sample data for the GPS system in 16 accordance with the above mentioned way by which we had diagnosed no cholangitis. We was less than 5%, as established by routine quality control procedures.
5
Briefly, patients with both an elevated CRP level (>10 mg/L) and hypoalbuminemia
6
(<35 g/L) were allocated a score of 2, while patients with only one of these biochemical 7 abnormalities were allocated a score of 1. Patients with neither of these abnormalities were 8 allocated a score of 0, as described previously.
13-15
Patients were followed regularly in outpatient clinics every 1-6 months. invasion, perineural invasion, surgical margin, CA19-9, and CEA were not found to be 16 significant predictors of survival.
17
Kaplan-Meier analysis demonstrated significant differences in survival among the GPS revealed that a GPS of 2 was an independent predictive factor of survival (HR=2.787, In this study, a Cox proportional hazards model revealed that a GPS of 2 was an 10 independent predictive factor of survival (Table 4 ). This data suggests that GPS is a 11 prognostic factor of outcome; higher GPS portends poor tumor biology and worse survival.
12
On the other hand, a Cox proportional hazards model revealed that lymph node metastasis 13 had a marginal significance for survival (HR=2.066, p=0.071) ( Acute-phase protein response and survival duration of patients with pancreatic cancer.
4
Cancer . 1995; 75:2077-82 . Survival curves stratified by Glasgow prognostic score (GPS) 0, 1, and 2.
3
There was a statistically significant difference among the three groups (five-year survival 4 rates: GPS of 0, 26.8%; GPS of 1, 42.6%; GPS of 2, 0%) (p=0.008). While there was a 5 significant difference between the GPS of 1 and the GPS of 2 (p=0.031), there was no 6 significant difference between the GPS of 0 and the GPS of 1 (p=0.866). Survival curves stratified by Glasgow prognostic score (GPS) 0-1 and 2.
10
There was a statistically significant difference between the GPS of 0-1 and the GPS of 2 11 (p=0.002). Survival curves stratified by lymph node status.
15
There was a statistically significant difference in survival between patients with positive 16 lymph nodes and those with negative nodes (p<0.001). 
